RxDoctor Payments Data

Candice Pych, APRN

Family · Manchester, CTNPI 1871563098

Payments from drug & device makers

$4,256in general payments, 2019–2025

Across 247 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$481
  • Phathom Pharmaceuticals, Inc.$324
  • Gilead$256
  • QOL Medical, LLC$227
  • Takeda Pharmaceuticals U.S.A., Inc.$203
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$4,19799%
  • Education$591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,256 in reported general payments places this provider in the 90th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut

Medicare billing

Part B allowed, 2024
$11,909
Medicare patients
119
Services billed
131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine ErMesalamine21$26,542
CreonLipase/Protease/Amylase16$23,795
LinzessLinaclotide25$21,455
Mesalamine46$15,484
Dexlansoprazole DrDexlansoprazole35$13,844
Omeprazole247$5,157
Sucralfate38$2,660
Ursodiol22$2,095
Lansoprazole40$1,580
Pantoprazole Sodium122$1,543
Esomeprazole Magnesium54$1,451
Famotidine84$1,124
Dicyclomine Hcl12$183

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,598$45,25041 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,596 family providers in Connecticut.

Other family in Manchester

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →